Retatrutide is a triple agonist research peptide targeting GLP-1, GIP and glucagon receptors. It is often called the next generation of metabolic research peptides.
How retatrutide works
Unlike single-receptor peptides, retatrutide activates three receptors at once. This triple mechanism is the reason it is generating so much research interest.
Research applications
Retatrutide is studied in metabolic, weight management and glucose regulation research. It is a research compound and is not approved for human use.
Retatrutide research peptide in Egypt
We supply retatrutide 10mg and 15mg research vials in Egypt, third party lab tested with published certificates and batch-coded for traceability. The R10 certificate reports 99.240% and 99.498% purity for the tested batch.
Important
Retatrutide is for research and laboratory use only, not for human or veterinary use.
View Retatrutide 10mg · View Retatrutide 15mg · View certificate